Jennifer Jarrett

Ms. Jennifer A. Jarrett is a President, Chief Executive Officer & Director at Damora Therapeutics, Inc., an Independent Director at Sagimet Biosciences, Inc., an Independent Director at Zura Bio Ltd. and an Independent Director at Syndax Pharmaceuticals, Inc. She is on the Board of Directors at Damora Therapeutics, Inc., Sagimet Biosciences, Inc., Cajal Therapeutics, Zura Bio Ltd., LifeMine Therapeutics, Inc., Syndax Pharmaceuticals, Inc. and SMART Reading /Oregon/.
Ms. Jarrett was previously employed as an Independent Director by Radius Health, Inc., an Independent Director by Consonance-HFW Acquisition Corp., a VP-Corporate Development & Capital Markets by Uber Technologies, Inc., a VP-Corporate Development & Capital Markets by Uber, Inc., an Independent Director by Arena Pharmaceuticals, Inc., an Independent Director by Audentes Therapeutics, Inc., a Chief Operating Officer by Arcus Biosciences, Inc., a Chief Financial Officer by Medivation LLC (California), a Chief Financial Officer by Medivation, Inc. /Old/, a Managing Director-Health Care Investment Banking by Citigroup, Inc., a Director & MD-Health Care Investment Banking by Credit Suisse Group AG, and an Associate by Donaldson, Lufkin & Jenrette International.
She received her undergraduate degree from Dartmouth College and an MBA from Stanford Graduate School of Business.